Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Status: Recruiting
Location: See all (7) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• 1.1 Age 18 years or older.
• 1.2 A diagnosis of cancer, cancer remission, benign disease (benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or hepatitis C virus infection, Chronic obstructive pulmonary disease, etc.) or apparently healthy volunteers. .
Locations
United States
California
Torrance Memorial Physician Network - Cancer Care
ACTIVE_NOT_RECRUITING
Redondo Beach
Minnesota
Allina Health, Virginia Piper Cancer Institute
RECRUITING
Coon Rapids
Virginia Piper Cancer Institute Mercy Hospital-Unity Campus
RECRUITING
Fridley
VPCI Oncology Research
RECRUITING
Minneapolis
Tennessee
Methodist LeBonheur Healthcare
RECRUITING
Memphis
Texas
Liver Center of Texas
RECRUITING
Dallas
Methodist Hospital
RECRUITING
Richardson
Contact Information
Primary
Clinical Operations Manager
octavia@heliogenomics.com
6263500537
Time Frame
Start Date: 2019-05-21
Estimated Completion Date: 2025-12
Participants
Target number of participants: 1200
Related Therapeutic Areas
Sponsors
Leads: Helio Genomics